Bicycle Therapeutics (BCYC) Profit After Tax (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Profit After Tax of -$62.6 million for Q1 2026, down 210.6% on a QoQ basis from -$20.2 million in Q4 2025, and little changed year-over-year from -$62.9 million in Q1 2025.
Bicycle Therapeutics (BCYC) Profit After Tax (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Profit After Tax history runs 9 years deep, the most recent figure standing at -$62.6 million for Q1 2026.
- Quarterly Profit After Tax changed 0.43% year-over-year to -$62.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$220.9 million (down 7.77% YoY) and the FY2025 annual result came in at -$219.0 million, down 29.56% from the prior year.
- Profit After Tax was -$62.6 million for Q1 2026 at Bicycle Therapeutics, down from -$20.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$20.2 million in Q4 2025 and bottomed at -$79.0 million in Q2 2025.
- A 5-year average of -$43.9 million and a median of -$42.6 million in 2023 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 59.65% in 2025, while the deepest fall reached 134.66% in 2025.
- Bicycle Therapeutics' Profit After Tax stood at -$30.0 million in 2022, then sank by 63.67% to -$49.1 million in 2023, then declined by 1.79% to -$49.9 million in 2024, then surged by 59.65% to -$20.2 million in 2025, then plunged by 210.6% to -$62.6 million in 2026.
- Business Quant data shows BCYC's Profit After Tax at -$62.6 million in Q1 2026, -$20.2 million in Q4 2025, and -$59.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -62.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.60 Mn |
| Dec 31, 2025 | -20.15 Mn |
| Sep 30, 2025 | -59.21 Mn |
| Jun 30, 2025 | -78.95 Mn |
| Mar 31, 2025 | -62.33 Mn |
| Dec 31, 2024 | -49.94 Mn |
| Sep 30, 2024 | -52.90 Mn |
| Jun 30, 2024 | -39.81 Mn |
| Mar 31, 2024 | -26.56 Mn |
| Dec 31, 2023 | -49.06 Mn |
| Sep 30, 2023 | -49.90 Mn |
| Jun 30, 2023 | -42.60 Mn |
| Mar 31, 2023 | -39.06 Mn |
| Dec 31, 2022 | -29.98 Mn |
| Sep 30, 2022 | -28.30 Mn |
| Jun 30, 2022 | -26.83 Mn |
| Mar 31, 2022 | -27.56 Mn |
| Dec 31, 2021 | -18.23 Mn |
| Sep 30, 2021 | -14.37 Mn |
| Jun 30, 2021 | -17.91 Mn |